Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ENDO INTERNATIONAL PLC

(ENDP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Market Chatter: Endo Pharmaceuticals Soars After Drug Maker Reportedly Proposes Settlement in 'Baby Doe' Opioid Case

07/20/2021 | 04:16pm EDT


© MT Newswires 2021
All news about ENDO INTERNATIONAL PLC
09/13PRO BANKRUPTCY BRIEFING : Hertz Seeks CEO After Bankruptcy; Delta Variant Renews..
DJ
09/10Health Care Down As Safe-Haven Appeal Wanes -- Health Care Roundup
DJ
09/10Take-Two, Apellis fall; Dave & Buster's, Endo rise
AQ
09/10Endo International Exploring Strategic Alternatives
CI
09/10Wall Street Set for Gains as Biden-Xi Call Lifts Sentiment
MT
09/10ENDO INTERNATIONAL : Agrees to $50 Million Settlement of New York Opioid Litigat..
MT
09/10ENDO INTERNATIONAL : Agrees to $50 Million Settlement of New York Opioid Litigat..
MT
09/09ENDO INTERNATIONAL : latest company to settle with New York over opioids
AQ
09/09ENDO INTERNATIONAL : Settles New York State Opioid Cases and Provides Update on ..
AQ
09/02ENDO INTERNATIONAL : S&P Downgrades Endo International Rating to 'CCC+' From 'B-..
MT
More news
Analyst Recommendations on ENDO INTERNATIONAL PLC
More recommendations
Financials (USD)
Sales 2021 2 773 M - -
Net income 2021 39,5 M - -
Net Debt 2021 6 736 M - -
P/E ratio 2021 4,64x
Yield 2021 -
Capitalization 661 M 661 M -
EV / Sales 2021 2,67x
EV / Sales 2022 2,54x
Nbr of Employees 3 397
Free-Float 98,5%
Chart ENDO INTERNATIONAL PLC
Duration : Period :
Endo International plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ENDO INTERNATIONAL PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Last Close Price 2,83 $
Average target price 6,57 $
Spread / Average Target 132%
EPS Revisions
Managers and Directors
Blaise A Coleman President, Chief Executive Officer & Director
Mark Bradley Chief Financial Officer & Executive Vice President
Mark G. Barberio Chairman
Ruth Thorpe Chief Information Officer
Robert Polke Global Head-Operations